Skip to content

Wednesday, May 14, 2025

Latest:

Dr. Margaret Goodell elected to the National Academy of Sciences
Healthy Habits: Dr. Samer Mattar enjoys walking on the treadmill
Urogynecology and Urology: What’s the difference?
A combined computational and experimental approach uncovered promising genetic players in Alzheimer’s disease
Healthy Habits: Group workouts motivate Dr. Jordana Faruqi

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Mpro

Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in the lab

August 31, 2021 COVID-19, COVID-19 drugs, DNA-Encoded Chemistry Technology., drug discovery, Mpro, Research, SARS-CoV-2

Baylor College of Medicine researchers are contributing to the development of antiviral drugs to treat people with COVID-19.

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951